H-1B sponsorship profile: Granules Pharmaceuticals Inc. Across U.S. Department of Labor LCA disclosures, Granules Pharmaceuticals Inc filed 86 Labor Condition Applications covering 86 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 100% (86 certified of 86 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Granules Pharmaceuticals Inc’s H-1B petitions range from $48,110 at the low end to $240,000 at the high end, with a petition-weighted average of $96,904. That range reflects the mix of occupations the company sponsors, led by Pharmaceutical Manufacturing Quality Control Analyst (9 petitions at $54,080 avg), followed by Biochemist and Biochemist I. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Granules Pharmaceuticals Inc is headquartered in Chantilly, VA under NAICS code 325412, and places H-1B workers across 1 state, most heavily in VA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Granules Pharmaceuticals Inc ranks. By H-1B petition volume, Granules Pharmaceuticals Inc is #2,674 of 119,880 employers nationally and #100 of 3,399 employers headquartered in VA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.